Literature DB >> 2156956

Psychiatric disorders in the encephalitic form of multiple sclerosis.

K Felgenhauer1.   

Abstract

Multiple sclerosis lesions may occur predominantly in the hemispheric white matter and cause various psychiatric disorders such as remitting-relapsing endoform or exogenous psychosis, organic personality alterations and dementia. Nineteen patients suffering from this encephalitic form of multiple sclerosis as diagnosed by characteristic CSF immunoglobulin findings are analysed according to established psychopathological criteria. All cases began with psychiatric symptoms and neurological signs were either absent or overlooked. Several patients developed typical encephalomyelitic symptoms in successive relapses, but other remained with psychiatric disorders over many years. Only four patients had retrobulbar neuritis, but seven suffered from epileptic seizures. The humoral immune response was characterized by a strong dominance of IgG and a local synthesis of polyspecific antibodies against measles, rubella and varicella/zoster virus. The mononuclear CSF pleocytosis was comparatively marked with cell counts up to 180/microliter.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156956     DOI: 10.1007/BF00319661

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  23 in total

1.  [Cerebral transmission syndrome as an early symptom of multiple sclerosis. Nuclear magnetic resonance tomography and psychological test case study].

Authors:  U Steller; U Beck
Journal:  Nervenarzt       Date:  1987-04       Impact factor: 1.214

2.  [Paranoid-hallucinatory psychosis as a manifestation of multiple sclerosis].

Authors:  B Piesiur-Strehlow; S Poser; K Felgenhauer
Journal:  Nervenarzt       Date:  1988-10       Impact factor: 1.214

3.  An investigation into some psychiatric aspects of multiple sclerosis.

Authors:  D Surridge
Journal:  Br J Psychiatry       Date:  1969-07       Impact factor: 9.319

4.  Diagnostic significance of IgG-synthesizing activated B cells in acute inflammatory diseases of the central nervous system.

Authors:  H J Schädlich; K Felgenhauer
Journal:  Klin Wochenschr       Date:  1985-06-03

5.  Acute paranoid psychosis in multiple sclerosis.

Authors:  M E Drake
Journal:  Psychosomatics       Date:  1984-01       Impact factor: 2.386

6.  Memory impairment in multiple sclerosis.

Authors:  M Carroll; R Gates; F Roldan
Journal:  Neuropsychologia       Date:  1984       Impact factor: 3.139

7.  Deficient learning and memory in early and middle phases of multiple sclerosis.

Authors:  I Grant; W I McDonald; M R Trimble; E Smith; R Reed
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-03       Impact factor: 10.154

8.  An anergic phase of disseminated sclerosis with psychotic course.

Authors:  J Můr; G Kümpel; S Dostál
Journal:  Confin Neurol       Date:  1966

9.  Depression as a major symptom of multiple sclerosis.

Authors:  F A Whitlock; M M Siskind
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-10       Impact factor: 10.154

10.  The demonstration of locally synthesized herpes simplex IgG antibodies in CSF by a Sepharose 4B linked enzyme immunoassay.

Authors:  K Felgenhauer; M Nekic; R Ackermann
Journal:  J Neuroimmunol       Date:  1982-10       Impact factor: 3.478

View more
  6 in total

1.  Schizophrenia, myelination, and delayed corollary discharges: a hypothesis.

Authors:  Thomas J Whitford; Judith M Ford; Daniel H Mathalon; Marek Kubicki; Martha E Shenton
Journal:  Schizophr Bull       Date:  2010-09-20       Impact factor: 9.306

2.  Dementia in two histologically confirmed cases of multiple sclerosis: one case with isolated dementia and one case associated with psychiatric symptoms.

Authors:  B Fontaine; D Seilhean; A Tourbah; C Daumas-Duport; C Duyckaerts; N Benoit; B Devaux; J J Hauw; G Rancurel; O Lyon-Caen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

Review 3.  Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations.

Authors:  Norbert Müller
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

Review 4.  Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein.

Authors:  Thalia F van der Doef; Janine Doorduin; Bart N M van Berckel; Simon Cervenka
Journal:  Clin Transl Imaging       Date:  2015-09-10

Review 5.  The role of inflammation in schizophrenia.

Authors:  Norbert Müller; Elif Weidinger; Bianka Leitner; Markus J Schwarz
Journal:  Front Neurosci       Date:  2015-10-21       Impact factor: 4.677

Review 6.  Neurobehavioral burden of multiple sclerosis with nanotheranostics.

Authors:  Bhasker Sriramoju; Rupinder K Kanwar; Jagat R Kanwar
Journal:  Neuropsychiatr Dis Treat       Date:  2015-10-15       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.